diaDexus
Focuses on the development and commercialization of cardiovascular diagnostic products addressing needs in cardiovascular disease.
Launch date
Employees
Market cap
-
Enterprise valuation
€33—50m (Dealroom.co estimates Feb 2009.)
San Francisco California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $103m | Series C | |
| N/A | N/A | IPO | |
$40.0m | Series E | ||
$9.2m | Series F | ||
$4.5m | Post IPO Debt | ||
$15.0m | Post IPO Debt | ||
N/A | Acquisition | ||
| Total Funding | €138m | ||